Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolastin-C for Islet Autograft Survival in Chronic Pancreatitis
NCT02947087Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2017
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic pancreatitis (CP) comparing Prolastin-C with Placebo (2 arms). Primary endpoint: Area Under the Curve for Serum C-peptide Level at 365 days. Started Jan 2017; status: completed.
02
Drugs
alpha1-proteinase inhibitor
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT02947087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02947087.